IMMUNIC, INC.
Develops oral small molecule therapies for chronic inflammatory and autoimmune diseases.
IMUX | US
Overview
Corporate Details
- ISIN(s):
- US4525EP1011 (+1 more)
- LEI:
- 549300R5T12FW5MEQB20
- Country:
- United States of America
- Address:
- 1200 AVENUE OF THE AMERICAS, 10036 NEW YORK
- Website:
- https://imux.com/
Description
Immunic, Inc. is a clinical-stage biopharmaceutical company focused on developing a pipeline of selective, orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. The company's mission is to create high-quality, oral treatment options that offer comprehensive therapeutic efficacy with favorable safety and tolerability profiles. Its clinical development programs target conditions with significant unmet medical needs, including multiple sclerosis and celiac disease, aiming to provide patients with convenient and effective solutions to manage debilitating symptoms and improve their quality of life.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Type / Size | Actions | |
|---|---|---|---|---|---|
| 2026-01-07 12:30 |
Immunic Highlights 2025 Accomplishments and Upcoming Milestones
|
English | HTML • 19.1 KB | ||
| 2025-11-26 12:30 |
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in…
|
English | HTML • 9.9 KB | ||
| 2025-11-14 21:04 | English | ZIP • 9.5 KB | |||
| 2025-11-14 14:39 | English | ZIP • 11.9 KB | |||
| 2025-11-13 12:30 |
Immunic, Inc. Reports Third Quarter 2025 Financial Results and Provides Corpora…
|
English | HTML • 22.9 KB | ||
| 2025-11-13 08:26 | English | ZIP • 115.6 KB | |||
| 2025-11-13 08:17 |
10-Q
|
English | ZIP • 9.7 MB | ||
| 2025-11-07 17:00 | English | ZIP • 10.8 KB | |||
| 2025-10-29 11:30 |
Immunic to Participate in Industry and Investor Conferences in November
|
English | HTML • 9.7 KB | ||
| 2025-10-01 12:30 |
Immunic to Participate in Scientific and Investor Conferences in October
|
English | HTML • 14.9 KB | ||
| 2025-09-25 12:30 |
Immunic Presented Key Vidofludimus Calcium Data at the 41st Congress of ECTRIMS…
|
English | HTML • 23.6 KB | ||
| 2025-09-25 09:01 | English | ZIP • 4.3 MB | |||
| 2025-09-09 12:30 |
Immunic Receives Notice of Allowance for United States Patent Protecting Vidofl…
|
English | HTML • 13.9 KB | ||
| 2025-09-04 12:30 |
Immunic to Participate in Investor and Scientific Conferences in September
|
English | HTML • 15.6 KB | ||
| 2025-08-27 18:06 | English | ZIP • 77.6 KB |
Automate Your Workflow. Get a real-time feed of all IMMUNIC, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for IMMUNIC, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for IMMUNIC, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
